GLP-1 Medications Challenge Fitness Pros, Sparking Industry Evolution
The rise of GLP-1 medications, like Semaglutide and Tirzepatide, has sparked concern among Americans and presented challenges for fitness professionals at Planet Fitness and beyond. A majority of Americans view these drugs as a shortcut, while trainers face issues like muscle loss and changes in body composition. Mike Fantigrassi, Head of Product at the National Academy of Sports Medicine (NASM), has highlighted the top challenge for personal trainers: GLP-1s. Nearly three-quarters of Americans are skeptical, with 60% worrying they bypass healthy habits. Trainers report that muscle loss is the primary issue, with 60% observing changes in body composition described as 'skinny fat'. To address these challenges, NASM has created a specialized course, Understanding Weight Loss Medications. The course aims to equip fitness professionals with the knowledge to navigate the impact of GLP-1s on their clients. Meanwhile, the industry's outlook remains positive, with 74% agreeing on the need for collaboration with medical providers. The role of fitness professionals is evolving, with 70% expecting a shift towards strength training and longevity coaching, away from traditional calorie burning and weight loss goals. GLP-1 medications, like Tirzepatide, pose significant challenges for fitness professionals, requiring them to adapt their approach and collaborate more closely with medical providers. Despite these hurdles, the industry's future looks promising, with a focus on strength training and longevity coaching.
